ECP
AGN

Empyrean Capital Partners’s Allergan plc AGN Stock Holding History

Empyrean Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,197,300
Closed -$212M – 79
2020
Q1 		$212M Sell
1,197,300
-76,200
-6% -$14.3M 14.58% 2
2019
Q4 		$243M Hold
1,273,500
– – 16.01% 1
2019
Q3 		$214M Buy
1,273,500
+246,300
+24% +$40.1M 11.15% 1
2019
Q2 		$172M Buy
+1,027,200
New +$142M 7.65% 2
2016
Q1 		– Sell
-179,210
Closed -$56M – 103
2015
Q4 		$56M Buy
179,210
+70,210
+64% +$20.9M 2.07% 16
2015
Q3 		$29.6M Sell
109,000
-336,753
-76% -$103M 1.46% 24
2015
Q2 		$135M Buy
445,753
+100,000
+29% +$29.8M 6.32% 3
2015
Q1 		$103M Sell
345,753
-198,247
-36% -$56.5M 5.12% 5
2014
Q4 		$140M Buy
+544,000
New +$136M 7.98% 1
2014
Q3 		– Sell
-318,000
Closed -$70.9M – 63
2014
Q2 		$70.9M Buy
+318,000
New +$65.8M 2.5% 12

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Empyrean Capital Partners's AGN Position: Q2 2020 in Review

Empyrean Capital Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,197,300 shares — an estimated $212M sold.

Empyrean Capital Partners first reported a position in AGN in Q2 2014 and held it in 10 quarters. The position peaked at $243M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Empyrean Capital Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Empyrean Capital Partners sold 1,197,300 Allergan plc shares in Q2 2020, an estimated $212M.
  • Empyrean Capital Partners first reported a position in Allergan plc in Q2 2014 and held it in 10 quarters.
  • Empyrean Capital Partners's Allergan plc position peaked at $243M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Empyrean Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.